This data supports our observations with Tregs from ovarian cancer ascites fluid and further suggests that Tregs of the tumor microenvironment in SS are not only expressing very high levels of TNFR2 but presumably are also rapidly proliferating from the overabundance of this growth receptor. This evidence concerns the gene TNFRSF1B and synovial sarcoma.